Understanding Genetic Overexpression in Down Syndrome: A Biochemical and Metabolic Perspective
Down syndrome (DS), or trisomy 21 (T21), occurs when a person has an extra copy of chromosome 21. This may seem small, but it creates a ripple effect throughout the body. Think of it like a recipe with one too many chefs in the kitchen; instead of harmony, you get overlapping instructions and too much of some ingredients, leading to chaos in the final dish. This genetic "overexpression" is at the heart of many of the classic features of Down syndrome: changes in facial structure, smaller stature, low muscle tone, congenital heart defects, and unique differences in immunity and cognition.
What Happens with Genetic Overexpression?
Let’s break it down: Genes act like factory workers producing tools (proteins) that keep the body functioning. In Down syndrome, some factories on chromosome 21 have double the workforce, churning out more tools than necessary. This overproduction can lead to:
Oxidative Stress: Too many tools create waste, like exhaust from an overworked engine.
Inflammation: Extra activity heats things up, similar to an engine overheating.
Disrupted Cell Signals: With so many tools, the body struggles to prioritize, like getting too many text notifications at once.
Key "factories" on chromosome 21 include:
DYRK1A (Dual specificity tyrosine-phosphorylation-regulated kinase 1A): A kinase that regulates neurodevelopment and cognitive function. Impacts brain development and memory, like an overzealous project manager trying to oversee every detail.
SOD1 (Superoxide Dismutase 1): Creates antioxidants to neutralize harmful molecules, but too much overwhelms the system with ROS (reactive oxygen species) like hydrogen peroxide. This is like adding water to a flood.
APP (Amyloid-beta Precursor Protein): Linked to the formation of amyloid plaques, contributing to Alzheimer's risk.
GRK (G-protein-coupled receptor kinases): Implicated in disrupted cellular signaling.
Epigenetics: Reprogramming the Symphony
Epigenetics is the study of how lifestyle and environment can "turn up" or "turn down" gene activity. If genes are the sheet music, epigenetics is the conductor shaping how the orchestra plays. Epigenetics is a fascinating and natural part of how our bodies work. At its core, it’s the mechanism by which our environment, lifestyle, diet, and even emotions interact with our genes, turning them on or off like light switches. It’s not about altering the DNA blueprint itself but rather how the body reads and interprets that blueprint. This process is profoundly natural and underscores how interconnected we are with our surroundings.
A Natural Design
Our bodies are designed to respond to cues from the environment through epigenetic changes. For example:
Food as Information: Nutrients from food don’t just fuel the body—they act as signals that influence gene expression. For instance, compounds like curcumin, resveratrol, and EGCG directly affect pathways related to inflammation, oxidative stress, and metabolism.
Lifestyle and Emotions: Stress, sleep, and even our emotional states leave epigenetic marks. Chronic stress, for instance, can suppress immune-supporting genes, while practices like mindfulness can restore balance.
Environment and Toxins: Our exposure to toxins or clean environments also affects gene expression. Reducing environmental stressors can prevent harmful genetic changes.
This dynamic adaptability is the body’s way of surviving and thriving in changing circumstances. From a biological perspective, it’s a survival mechanism—our genes adjust to match the conditions around us.
Relating Epigenetics to the FDN Approach
The FDN framework of DRESS (Diet, Rest, Exercise, Stress reduction, and Supplementation) aligns seamlessly with the concept of epigenetics. Each pillar supports the body’s innate capacity to regulate gene expression naturally:
Diet: Whole, nutrient-dense foods provide the epigenetic signals needed for healthy gene activity. Nutrients like methyl donors (found in leafy greens, eggs, and fish) support DNA methylation, a key epigenetic process.
Rest: Quality sleep resets the epigenome, allowing the body to repair damage and regulate stress responses.
Exercise: Physical activity promotes beneficial epigenetic changes, including genes related to metabolism and anti-inflammatory pathways.
Stress Reduction: Chronic stress alters epigenetic patterns, while stress management techniques restore healthy regulation.
Supplementation: Targeted nutrients like those used in TNI (curcumin, resveratrol, EGCG) provide tools for fine-tuning overexpressed or underexpressed genes.
TNI: Supporting Epigenetics in Down Syndrome
In the context of Down syndrome, Targeted Nutritional Intervention (TNI) provides parents with practical tools to support their child’s epigenetic health. By choosing nutrients that modulate overexpressed genes like DYRK1A, SOD1, and APP, parents can harness this natural process to restore balance. For instance:
Curcumin reduces inflammation and oxidative stress.
Curcumin has been shown to upregulate antioxidant enzymes, including catalase and glutathione peroxidase, through activation of Nrf2 (Nuclear factor erythroid 2-related factor 2). Nrf2 binds to antioxidant response elements (ARE) in DNA, promoting the expression of detoxifying and antioxidant enzymes
Helps balance the "factory" making proteins related to Alzheimer’s.
Analogy: Think of it as an antioxidant superhero fighting off harmful molecules.
Resveratrol activates longevity genes (SIRT1) and enhances detoxification pathways.
Resveratrol activates SIRT1 (Sirtuin 1) and AMPK (AMP-activated protein kinase), which indirectly influence Nrf2 pathways. This activation enhances the expression of catalase and other antioxidant enzymes, helping to restore redox balance in the presence of oxidative stress caused by SOD1 overexpression
Boosts the body’s natural cleanup crew (enzymes like catalase).
Analogy: It’s like hiring extra janitors to keep the factory floor clean.
EGCG directly interacts with DYRK1A, mitigating its overactivity.
While EGCG primarily acts as a direct scavenger of ROS, it also activates Nrf2 and other pathways that upregulate catalase and peroxidase activity, contributing to an overall reduction in oxidative stress.
Specifically "quiets down" DYRK1A, improving memory and learning.
Analogy: It’s like giving the brain’s noisy worker bees a coffee break.
When combined with other DRESS pillars, TNI becomes part of a comprehensive strategy that empowers families to support their child’s health without fear. It’s not a mysterious or clinical concept; it’s simply working with the body’s natural design.
Empowering Parents
Epigenetics may sound complex, but it’s as natural as breathing. Parents can feel confident knowing they’re supporting their child’s health in ways that align with the body’s innate intelligence. By integrating TNI with foundational lifestyle practices, families can create a supportive environment where genes express themselves in the most balanced way possible. I include TNI support in all client programs for individuals with Down syndrome. Additionally, I offer standalone TNI appointments for those needing targeted assistance.
For more support and community, join my private Find Empowered Health Facebook group, and the Down Syndrome Optimal Health Strategies group to learn more about TNI. If you have a child or loved one struggling with signs of Down syndrome regression or Down Syndrome Regression Disorder (DSRD), I highly recommend you join the TNI-Restoring Hope for Down Syndrome Regression Facebook group. These are safe and supportive spaces to connect with other families and learn more at your own pace.
For a deeper dive into TNI, epigenetics, and Down syndrome, check out my talk at the Down Syndrome Innovations Conference 2023.
Glossary of Terms
Down syndrome (DS): A genetic condition caused by an extra copy of chromosome 21, leading to overexpression of certain genes and associated physical, cognitive, and health-related features.
Trisomy 21 (T21): Another term for Down syndrome, highlighting the presence of a third copy of chromosome 21.
Genetic Overexpression: When a gene produces more of its protein product than normal, potentially disrupting biological processes.
DYRK1A: A gene on chromosome 21 involved in brain development and cognitive function; overexpression is linked to neurodevelopmental differences in DS.
SOD1 (Superoxide Dismutase 1): A gene that produces an antioxidant enzyme; overexpression can lead to oxidative stress in DS.
APP (Amyloid-beta Precursor Protein): A gene associated with the production of amyloid plaques, increasing Alzheimer’s disease risk in DS.
Oxidative Stress: An imbalance between the production of harmful molecules (reactive oxygen species) and the body’s ability to neutralize them.
Epigenetics: The study of how environmental factors, lifestyle, and diet can influence gene expression without changing the DNA sequence.
Nrf2 (Nuclear factor erythroid 2-related factor 2): A protein that regulates the expression of antioxidant and detoxifying enzymes.
TNI (Targeted Nutritional Intervention): A personalized nutritional approach aimed at modulating gene activity to address specific needs in individuals with DS.
DRESS Protocol: A holistic health framework focusing on Diet, Rest, Exercise, Stress reduction, and Supplementation.
Sources
Meguid, N A et al. “Evaluation of superoxide dismutase and glutathione peroxidase enzymes and their cofactors in Egyptian children with Down's syndrome.” Biological trace element research vol. 81,1 (2001): 21-8. doi:10.1385/BTER:81:1:21
Moyer, Anna J et al. “All Creatures Great and Small: New Approaches for Understanding Down Syndrome Genetics.” Trends in genetics : TIG vol. 37,5 (2021): 444-459. doi:10.1016/j.tig.2020.09.017
De Toma, I et al. “Where Environment Meets Cognition: A Focus on Two Developmental Intellectual Disability Disorders.” Neural plasticity vol. 2016 (2016): 4235898. doi:10.1155/2016/4235898
Trisomy 21 Research. "The Gelb Study on Nutrivene." Trisomy 21 Research Foundation, 19 Sept. 2017, https://trisomy21research.org/2017/09/19/the-gelb-study-on-nutrivene/. Accessed 4 Dec. 2024.
Soppa, Ulf et al. “The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiation.” Cell cycle (Georgetown, Tex.) vol. 13,13 (2014): 2084-100. doi:10.4161/cc.29104
Yin, X., Jin, N., Shi, J. et al. Dyrk1A overexpression leads to increase of 3R-tau expression and cognitive deficits in Ts65Dn Down syndrome mice. Sci Rep 7, 619 (2017). https://doi.org/10.1038/s41598-017-00682-y
Neumann, F., Gourdain, S., Albac, C. et al. DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives. Sci Rep 8, 2859 (2018). https://doi.org/10.1038/s41598-018-20984-z
Stringer, Megan et al. “Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits.” Molecular genetics & genomic medicine vol. 5,5 451-465. 20 Sep. 2017, doi:10.1002/mgg3.334
Daniela Valenti, Lidia de Bari, Domenico de Rasmo, Anna Signorile, Alexandra Henrion-Caude, Andrea Contestabile, Rosa Anna Vacca, The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down syndrome mouse model, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Volume 1862, Issue 6, 2016, Pages 1093-1104, ISSN 0925-4439, https://doi.org/10.1016/j.bbadis.2016.03.003.
De la Torre, Rafael et al. “Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans.” Molecular nutrition & food research vol. 58,2 (2014): 278-88. doi:10.1002/mnfr.201300325
Jurrmann, Nadine et al. “Curcumin blocks interleukin-1 (IL-1) signaling by inhibiting the recruitment of the IL-1 receptor-associated kinase IRAK in murine thymoma EL-4 cells.” The Journal of nutrition vol. 135,8 (2005): 1859-64. doi:10.1093/jn/135.8.1859
Oh, Jin-Gyo et al. “Direct regulation of IL-2 by curcumin.” Biochemical and biophysical research communications vol. 495,1 (2018): 300-305. doi:10.1016/j.bbrc.2017.11.039
Mishra, Shrikant, and Kalpana Palanivelu. “The effect of curcumin (turmeric) on Alzheimer's disease: An overview.” Annals of Indian Academy of Neurology vol. 11,1 (2008): 13-9. doi:10.4103/0972-2327.40220
Valle, Nicolas, et al. "Reduction of DYRK1A Expression and Activity as a Therapeutic Strategy in Down Syndrome." Journal of Biological Chemistry, vol. 295, no. 26, 2019, pp. 8952-8968, https://www.jbc.org/article/S0021-9258(19)63096-6/fulltext. Accessed 4 Dec. 2024.
Garcia-Alloza, M., Borrelli, L.A., Rozkalne, A., Hyman, B.T. and Bacskai, B.J. (2007), Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. Journal of Neurochemistry, 102: 1095-1104. https://doi.org/10.1111/j.1471-4159.2007.04613.x
Dragonieri, Silvano et al. “S-Adenosylmethionine May Mitigate Obstructive Sleep Apnea in an Adult with Down Syndrome: A Case Report.” Nature and science of sleep vol. 14 175-178. 4 Feb. 2022, doi:10.2147/NSS.S350350
Valero, Teresa. “Mitochondrial biogenesis: pharmacological approaches.” Current pharmaceutical design vol. 20,35 (2014): 5507-9. doi:10.2174/138161282035140911142118
Feki, A., & Hibaoui, Y. (2018). DYRK1A Protein, A Promising Therapeutic Target to Improve Cognitive Deficits in Down Syndrome. Brain Sciences, 8(10), 187. https://doi.org/10.3390/brainsci8100187
Atas-Ozcan, H., Brault, V., Duchon, A., & Herault, Y. (2021). Dyrk1a from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome. Genes, 12(11), 1833. https://doi.org/10.3390/genes12111833
Fernandes, Guilherme Felipe Santos et al. “Epigenetic Regulatory Mechanisms Induced by Resveratrol.” Nutrients vol. 9,11 1201. 1 Nov. 2017, doi:10.3390/nu9111201
Vacca, Rosa Anna et al. “Plant polyphenols as natural drugs for the management of Down syndrome and related disorders.” Neuroscience and biobehavioral reviews vol. 71 (2016): 865-877. doi:10.1016/j.neubiorev.2016.10.023
The content on this blog is for informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or qualified health practitioner with any questions you may have regarding a medical condition.
The information provided here is based on my professional experience, personal research, and the cited sources. While I strive to share accurate and helpful insights, the effectiveness of any suggestions or practices may vary depending on individual circumstances.
By using this website, you acknowledge that any reliance on the information provided is solely at your own risk. I encourage you to consult a healthcare professional before making significant changes to your diet, supplements, or lifestyle, especially if you have pre-existing conditions, are pregnant, or are taking medications.
